From NBC Universal: 2024-09-25 11:01:37

In a new study, Novo Nordisk’s diabetes drug Ozempic may lower the risk of opioid overdoses in patients with Type 2 diabetes and opioid use disorder. Only about a quarter of patients with opioid use disorder receive recommended medications, leading to a need for new alternatives to prevent overdoses. The study analyzed electronic health records of nearly 33,000 patients prescribed semaglutide or other diabetes medications. Over a one-year period, patients who took semaglutide had a 58% lower risk of opioid overdose compared to those who took other drugs. Researchers hope to conduct more studies to confirm the benefits of GLP-1 medications like Ozemptic in treating opioid use disorders and preventing overdoses.



Read more at NBC Universal: Novo Nordisk’s Ozempic may lower risk of opioid overdoses: study